Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Surg Neurol. 2006 Nov;66(5):539-43; discussion 543. Epub 2006 Jul 21.

Primary malignant B-cell-type dural lymphoma: Case report.

Author information

  • 1Department of Neurosurgery, Kochi University School of Medicine, Nankoku-City, Kochi-Prefecture 783-8505 Japan. yamadasm@med.kochi-u.ac.jp

Abstract

BACKGROUND:

The primary malignant dural lymphoma of B-cell type is rare. Our review of the literature (24 cases) indicated that patients with this tumor had female predominance, immunocompetency, and longer survival compared with those with primary malignant intracerebral lymphomas. Based on its clinicopathological features, this dural lymphoma may be classified differently from other types of malignant lymphomas in the central nervous system.

CASE DESCRIPTION:

The authors report an example of a patient who had a favorable course of malignant dural lymphoma. A 59-year-old woman presented with primary malignant dural lymphoma in the frontal area. Histological diagnosis was a diffuse large B-cell-type lymphoma of intermediate malignancy, but MIB-1 index was extremely high. Subtotal tumor removal was followed by 4 courses of chemotherapy. Thirty months after surgery, the patient is asymptomatic with no MRI evidence of recurrence. A combination of subtotal resection and chemotherapy for a primary malignant dural lymphoma is an effective means to attempt cure of this tumor.

CONCLUSION:

These rare tumors may be managed successfully by subtotal resection and postoperative treatment. We believe that chemotherapy is the treatment of choice after subtotal resection of malignant dural lymphomas, as experienced in our case.

PMID:
17084207
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk